Adage Capital Partners Gp, L.L.C. Karuna Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $17.3 Million - $38.8 Million	-140,000 Reduced 50.91%	135,000 $30.4 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $11.7 Million - $17.9 Million	-125,000 Reduced 31.25%	275,000 $34.8 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $27.8 Million - $37.2 Million	281,406 Added 237.29%	400,000 $50.7 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $13.1 Million - $18.9 Million	118,594 New	118,594 $15.5 Million

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.